B Braun buys $63m parenterals firm for Asian growth
This article was originally published in Clinica
B Braun, a leading player in medical devices, critical care, surgical instruments and renal care therapy, has acquired 75% of Ahlcon Parenterals, as part of the German multinational's strategy to accelerate growth in India and other markets in the region.
You may also be interested in...
Scrip traces some of the prominent changes in the corner office at front-line, family-owned Indian firms Cipla and Dr Reddy’s in the decade gone by.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.